Tauroursodeoxycholic Acid

Tauroursodeoxycholic Acid
Product Description

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Tauroursodeoxycholic Acid. It belongs to new products category. Therapeutic category: Bile Stone Therapy. Contact us for more information.

Dipharma

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer
Specifications
  • CAS Registry Number
    14605-22-2

Dipharma

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer

More Products from Dipharma (40)

  • Nortriptyline Hydrochloride

    Product Nortriptyline Hydrochloride

    Dipharma manufactures wide range of active pharmaceutical ingredients which includes Nortriptyline Hydrochloride. It belongs to commercial products category. Therapeutic category: Antidepressant. Contact us for more information.
  • Pirfenidone

    Product Pirfenidone

    Dipharma manufactures wide range of active pharmaceutical ingredients which includes Pirfenidone. It belongs to new products category. Therapeutic category: Immunosuppressant. Contact us for more information.
  • Piroxicam

    Product Piroxicam

    Dipharma manufactures wide range of active pharmaceutical ingredients which includes Piroxicam. It belongs to commercial products category. Therapeutic category: Anti-inflammatory. Contact us for more information.
  • Rufinamide

    Product Rufinamide

    Dipharma manufactures wide range of active pharmaceutical ingredients which includes Rufinamide. It belongs to new products category. 
    Therapeutic category: Anticonvulsant.
    Contact us for more information.
  • Selegiline Base*

    Product Selegiline Base*

    Dipharma manufactures wide range of active pharmaceutical ingredients which includes Selegiline Base*. It belongs to new products category. Therapeutic category: Antidepressant, Antiparkinson. Contact us for more information.
    * only for specific markets. See our website
  • Selegiline Hydrochloride

    Product Selegiline Hydrochloride

    Dipharma manufactures wide range of active pharmaceutical ingredients which includes Selegiline Hydrochloride. It belongs to commercial products category. Therapeutic category: Antiparkinsonian. Contact us for more information.
  • Tolbutamide

    Product Tolbutamide

    Dipharma manufactures wide range of active pharmaceutical ingredients which includes Tolbutamide. It belongs to commercial products category. Therapeutic category: Antidiabetic. Contact us for more information.
  • Triamterene

    Product Triamterene

    Dipharma manufactures wide range of active pharmaceutical ingredients which includes Triamterene. It belongs to commercial products category. Therapeutic category: Diuretic. Contact us for more information.
  • Varenicline Tartrate

    Product Varenicline Tartrate

    Dipharma manufactures wide range of active pharmaceutical ingredients including Varenicline Tartrate, a smoking-cessation product, which is nitrosamine free due to the dedicated process developed. Contact us for more information.

  • Ursodeoxycholic Acid

    Product Ursodeoxycholic Acid

    Dipharma manufactures wide range of active pharmaceutical ingredients which includes Ursodeoxycholic Acid. It belongs to commercial products category. Therapeutic category: Cholelitholytic Agent. Contact us for more information.
  • Vortioxetine HBr

    Product Vortioxetine HBr

    Dipharma manufactures wide range of active pharmaceutical ingredients which includes Vortioxetine HBr. It belongs to new products category. Therapeutic category: Antidepressant. Contact us for more information.
  • Zonisamide

    Product Zonisamide

    Dipharma manufactures wide range of active pharmaceutical ingredients which includes Zonisamide. It belongs to commercial products category. Therapeutic category: Anticonvulsant. Contact us for more information.

Dipharma resources (4)

  • News Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA

    Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process. The Company expands its range of CGMP services to include small-scale commercial APIs.
  • Video Development and Manufacturing of New APIs: Leveraging Experience, Technological Innovation, and Present Vision to Future Success.

    In today’s globalized economy, international integration plays a crucial role in the development of new molecules. This integration encompasses various aspects, including the transfer of production activities and the utilization of past experiences. Risk and Innovation: The development of APIs (active pharmaceutical ingredients) utilizes innovative process techniques and potentially hazardous chemical reactions. Leveraging past experiences is essential to mitigate risks and optimize production. Solid-State Development: A deep understanding of solid-state properties is critical for API manufacturers. Solid-state characterization ensures product stability, bioavailability, and manufacturability.
  • News Dipharma expands its Italian R&D Center to increase its analytical services

    The Company strengthens its analytical R&D capabilities, to better support its customers operating in the CDMO and Generics market.

  • Video The Dipharma Group - Experience you can trust

    The Dipharma Group is a global Contract Development and Manufacturing Organization (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCE), and advanced Intermediates for Generic and Contract Manufacturing markets, offering APIs with DMFs registered worldwide.